Independent medicine information from a GPhC-registered UK pharmacy · Checked against NHS, MHRA and NICE sources

Medicine information

Is zopiclone a strong sleeping pill?

Zopiclone is prescription-only and a controlled drug, so it is stronger than anything available over the counter. But NICE and the ACMD found no firm evidence that it outperforms other UK sleeping tablets. Here is what actually decides whether it helps.

Last updated 16 November 2026

Written by the Your Meds UK editorial team · Sources: NHS, MHRA, NICE, EMC

Illustration of empty brass balance scales resting level on a shelf beside closed books

Is zopiclone a strong sleeping pill? It is a prescription-only hypnotic and a controlled drug, so it is stronger than anything available over the counter. But the comparison most people want does not exist. NICE and the Advisory Council on the Misuse of Drugs both looked for meaningful differences in power between zopiclone, the other Z-drugs and the older sleeping tablets, and found no firm evidence of any.

Key facts

  • What it is: A hypnotic (sleeping tablet) from the cyclopyrrolone group, one of the medicines known as Z-drugs.
  • Licensed use (UK): Short-term treatment of insomnia in adults, where the insomnia is debilitating or causing severe distress.
  • Legal status: Class C controlled drug, Schedule 4 Part I.
  • Needs a prescription: Yes
  • Last checked: November 2026

So is zopiclone a strong sleeping pill?

It is a real hypnotic medicine, not a herbal aid. It is only available on prescription, and it is a controlled drug. In that sense it sits at the stronger end of what is available in the UK.

What it is not is the “strongest” option in some league table. In 2004 NICE looked at zaleplon, zolpidem and zopiclone together. It found no firm evidence of differences in the effects of these medicines and the shorter-acting benzodiazepines.

The Advisory Council on the Misuse of Drugs reached the same conclusion in 2013. Reviewing the evidence on Z-drugs, it reported no very significant differences in therapeutic efficacy or adverse effect potential between the benzodiazepines and the Z-drugs, or between the individual Z-drugs.

Two expert bodies, approaching the question differently, reached the same conclusion. If you are hoping one tablet simply works harder, the evidence does not support that.

What zopiclone is licensed to treat in the UK

Zopiclone sleeping pills are licensed for the short-term treatment of insomnia in adults. The Summary of Product Characteristics covers difficulty falling asleep, waking in the night and waking too early. It includes transient, situational and chronic insomnia.

The licence is not written for mild or occasional poor sleep. It describes situations where the insomnia is debilitating or is causing severe distress. The same document says long-term continuous use is not recommended, and that a course should use the lowest effective dose.

Why “strongest sleeping tablet” is the wrong question

NICE was clear about what should happen when one of these medicines does not help. If treatment with one hypnotic does not work, your doctor should not simply prescribe one of the others. Switching is advised only when side effects occur that are directly related to the medicine.

NICE also recommended prescribing the cheapest of these drugs, taking the daily dose and cost per dose into account. A guideline body does not say that about medicines it believes differ in power.

So if zopiclone is not helping, reaching for something billed as stronger is not the answer. Our guide on what to do when zopiclone stops working covers what your prescriber will look at instead.

What actually predicts whether a sleeping tablet helps is more ordinary: whether insomnia is the right diagnosis, whether something else is disturbing your sleep, whether the course is short enough to avoid tolerance, and whether bedtime habits are changing too.

The strengths it comes in, and why yours may be lower

In the UK, zopiclone tablets come in 3.75 mg and 7.5 mg. The licensed adult dose is one 7.5 mg tablet shortly before bed. Always take it exactly as your prescriber tells you.

The SmPC directs a lower 3.75 mg starting strength for several groups: older people, people with liver problems, people with reduced kidney function, and people with chronic respiratory insufficiency.

This is not because their insomnia is milder. It is because the medicine clears more slowly or the risks are higher. In older people the elimination half-life lengthens to roughly 7 hours, against about 5 hours in other adults.

A lower strength is a sign the dose has been matched to you, not a sign of a weaker prescription. Never change your own strength, and never take a second tablet in the same night. You can read more in our guide to zopiclone doses.

How long a course should last

This is where zopiclone differs most from the picture of a powerful tablet you take whenever sleep is poor.

The SmPC sets out short periods: 2 to 5 days for transient insomnia, and 2 to 3 weeks for short-term insomnia. A single course should not continue for longer than 4 weeks, and that 4 weeks includes any tapering off. Going beyond the maximum period should not happen without your prescriber re-assessing you.

The NHS puts it in plainer terms. Treatment usually lasts from a few days to a few weeks, and it is not usually prescribed for more than 4 weeks, because your body gets used to it and it stops working as well.

That is tolerance, and it is the real reason people start wondering whether they need something stronger. The tablet has not become weak. The response to it has changed.

What recent MHRA action tells you

In January 2026 the MHRA announced it was strengthening dependency and addiction warnings on medicines used for pain, anxiety and insomnia. The change covers gabapentinoids, benzodiazepines and Z-drugs, the group zopiclone belongs to.

Packs and patient leaflets are being updated to carry the warning that these medicines may cause addiction, dependence and withdrawal reactions. Leaflets will also give clearer definitions of dependence and better guidance on stopping safely.

The accompanying Drug Safety Update makes an important point: these effects can also occur with short-term use at recommended therapeutic doses. It also advises that you should never stop taking your medication without asking a healthcare professional first.

A regulator does not strengthen warnings on a weak medicine. Our article on whether zopiclone is addictive goes into this in more detail.

What its legal status tells you about its risk

Zopiclone is a Class C drug under Schedule 2, Part III of the Misuse of Drugs Act 1971. It also sits in Schedule 4, Part I of the Misuse of Drugs Regulations 2001, alongside zaleplon and zolpidem. It was brought under control on 10 June 2014.

The reasoning came from that same ACMD review. It recommended controlling zaleplon and zopiclone to bring them in line with zolpidem, because the harms of all three were commensurate with Class C and Schedule 4 Part I control, and the existing position was an anomaly.

That answers the strength question from another direction. Zopiclone was not controlled for being uniquely powerful, but for being no less risky than medicines already controlled. See our explainer on zopiclone’s controlled-drug status.

The next day: drowsiness, driving and the law

A tablet that lasts into the morning can feel strong for the wrong reason. The SmPC cautions against driving, and taking zopiclone within 12 hours of anything needing mental alertness is listed as a risk factor. The NHS says plainly not to drive, ride a bike or use machinery for 12 hours after taking it.

Under UK drug-driving law, prescribed medicines are included. It is an offence to drive if you are unfit through legal drugs, and being prescribed the medicine is no defence if it is making you unfit to drive. Penalties start at a minimum one-year driving ban.

If you feel dazed, slow or sleepy the next morning, do not drive, and speak to your prescriber or pharmacist.

What to try instead, or alongside

The NHS insomnia page says GPs now rarely prescribe sleeping pills, because they can have serious side effects and you can become dependent on them. Where they are used, it is only for a few days, or weeks at the most.

Insomnia usually improves by changing sleeping habits. The NHS advises going to bed only when sleepy, winding down for an hour beforehand, and avoiding caffeine or alcohol for six hours before bed. Cognitive behavioural therapy is sometimes offered, face to face or online.

None of this is a weaker version of a sleeping tablet. It is the part that keeps working after the four weeks are up.

When to get help

Call 999 or go to A&E if someone who has taken zopiclone has very slow or shallow breathing, cannot be woken, is confused and drowsy together, or has blue-tinged lips. The risk is far higher if the medicine was taken with alcohol or an opioid.

Call NHS 111 or speak to your GP urgently if you have taken more than you were prescribed, if you experience memory gaps, hallucinations, or sleepwalking or other activity while not fully awake, or if your mood drops sharply.

Speak to your prescriber or pharmacist, without stopping the medicine yourself, if the tablets no longer help, if you feel you need them to sleep at all, or if you are drowsy the next morning. Never stop suddenly.

You can report a suspected side effect through the MHRA Yellow Card scheme.

Frequently asked questions

What are the strongest sleeping tablets in the UK?

There is no agreed answer, and that is the point. NICE found no firm evidence of differences in effect between zopiclone, zolpidem, zaleplon and the shorter-acting benzodiazepines. Ranking them by strength is not something UK guidance supports, and only a prescriber can decide what is appropriate for you.

Are zopiclone sleeping pills stronger than over-the-counter ones?

They work differently. Zopiclone is a prescription-only hypnotic and a controlled drug, while pharmacy sleep aids are generally sedating antihistamines. The NHS says pharmacy aids should not be taken for longer than one to two weeks. Neither is a long-term answer to insomnia.

Why does my zopiclone feel weaker than it used to?

That is usually tolerance. The NHS explains that zopiclone is not usually prescribed for more than four weeks because the body gets used to it and it stops working as well. Do not increase your dose. Go back to your prescriber, who will reassess what is keeping you awake.

Is zopiclone the same as a benzodiazepine?

No. Zopiclone belongs to the cyclopyrrolone group and acts at a different site on the same GABA receptor complex. In practice the ACMD found no very significant differences in efficacy or adverse effects between the two. Our guide on zopiclone and benzodiazepines explains more.

Is zopiclone or zolpidem better for sleep?

UK guidance does not rank one above the other. NICE advises that if one of these hypnotics does not work, your doctor should not simply prescribe another of them. We compare the two in our guide to zopiclone and zolpidem.

References

  1. Zopiclone 7.5mg film-coated tablets — Summary of Product Characteristics, electronic medicines compendium (emc), last updated 5 February 2026. Accessed November 2026.
  2. Zopiclone, NHS, page last reviewed 22 June 2026. Accessed November 2026.
  3. Insomnia, NHS, page last reviewed 19 March 2024. Accessed November 2026.
  4. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (TA77), National Institute for Health and Care Excellence. Accessed November 2026.
  5. ACMD advice on Z-drugs: a review of the evidence of misuse and harm, Advisory Council on the Misuse of Drugs, 5 September 2013. Accessed November 2026.
  6. The Misuse of Drugs Regulations 2001, Schedule 4, legislation.gov.uk. Accessed November 2026.
  7. Misuse of Drugs Act 1971, Schedule 2, legislation.gov.uk. Accessed November 2026.
  8. MHRA strengthening dependency and addiction warnings on medicines used to treat pain, anxiety, and insomnia, Medicines and Healthcare products Regulatory Agency, 8 January 2026. Accessed November 2026.
  9. Improving information supplied with gabapentinoids, benzodiazepines and Z-drugs, MHRA Drug Safety Update, volume 19, issue 6, January 2026. Accessed November 2026.
  10. Drugs and driving: the law, GOV.UK. Accessed November 2026.

This article is for information only and does not replace advice from your doctor or pharmacist. Read our medical disclaimer.

Questions about your own medicine?

Speak to the doctor or pharmacist who looks after you before you start, change or stop any medicine. If you think you are having a serious reaction, call 999.